FIGURE 2. Comparison of planar imaging of head and neck region of patient 1 21 h after administration of 99mTc-cMAb U36 (A) and 186Re-cMAb U36 (B). Accumulation of radiolabeled cMAb U36 is visible at tumor recurrence in right oropharynx.